Coeptis Therapeutics, Inc. Long-Term Debt, Maturity, Year Five
Coeptis Therapeutics, Inc. had Long-Term Debt, Maturity, Year Five of $3.13 thousand as of 2022-06-30, per its 10-Q filed 2022-08-02.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2022-11-08
- 2022-06-30: Long-Term Debt, Maturity, Year Five $3.13K.
- 2021-12-31: Long-Term Debt, Maturity, Year Five $0.00.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2022-06-30 | $3.13K 10-Q · filed 2022-08-02 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 |